Is the World Health Organization-recommended dose of pralidoxime effective in the treatment of organophosphorus poisoning? A randomized, double-blinded and placebo-controlled trial
Background: Organophosphorus poisoning (OPP) is a major global public health problem. Pralidoxime has been used in a complimentary role to atropine for the management of OPP. World Health Organization (WHO) recommends use of pralidoxime but studies regarding its role have been inconclusive, ranging...
Main Authors: | Sumaya Syed, Showkat Ahmad Gurcoo, Ayaz Khalid Farooqui, Waqarul Nisa, Khalid Sofi, Tariq M Wani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Saudi Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2015;volume=9;issue=1;spage=49;epage=54;aulast=Syed |
Similar Items
-
A Study on Two Dose Regimens of Pralidoxime in the Management of Organophosphate Poisoning
by: Mahadevaiah Mahesh, et al.
Published: (2013-12-01) -
Relevance of Plasma Cholinesterase to Clinical Findings in Acute Organophosphorous Poisoning
by: Devanur R.M.M. Prasad, et al.
Published: (2013-03-01) -
Intermediate syndrome following organophosphate poisoning: A case report in a low resource and poor socio‐economic setting
by: Nimesh Lageju, et al.
Published: (2022-10-01) -
Computational Design, Molecular Docking Study and Toxicity Prediction of Some Novel Pralidoxime Derivatives as reactivators of acetyl cholinesterase enzyme
by: abozar roeintan
Published: (2019-04-01) -
Effects of Standard Treatment Alone Versus Standard Treatment plus Plasmapheresis on the Levels of Serum Pseudocholinesterase and Erythrocyte Acetylcholinesterase in Critically Patients with Organophosphate Poisoning: Randomized Controlled, Open-label, Clinical Trial
by: Muhammet Güven, et al.
Published: (2023-10-01)